About your Doctor

Education:

Undergraduate:
1966
Summa cum laude, English Literature and Zoology
Univeristy of Minnesota, Minneapolis, MN

Graduate:

1970
Doctor of Medicine
University of Minnesota School of Medicine, Minneapolis, MN

Postgraduate Training:

1970 - 71
Intern in Medicine
Presbyterian Hospital, San Francisco, CA

1971-73
Resident in Pathology
Presbyterian Hospital, San Francisco, CA

1973-75
Resident in Internal Medicine
Presbyterian Hospital, San Francisco, CA

Board Certification:

Board Certification in Internal Medicine, 1975
Board Certification in Hematology, 1978
Board Certification in Medical Oncology, 1979

Medical Licensure:

1971 State of Minnesota
1972 State of California, C34434

Professional Experience:

1978 - 80
Medical Director of Outpatient Clinics, Pacific Presbyterian Hospital
San Francisco, CA

1978 - Present
Private practice of Medical Oncology and Hematology
San Francisco, CA

1978 - Present Member of Attending Staff, California Pacific Medical Center
San Francisco, CA

1978 - 94
Chief, Division of Oncology
Pacific Presbyterian Medical Center
San Francisco, CA

1978 - 80
Chief Instructor of Medical Residents, Pacific Presbyterian Medical Center
San Francisco, CA

1982-92
Director, Adult Oncology Unit, Pacific Presbyterian Medical Center
San Francisco, CA

1987 - 90
Board of Directors, Cancer Support Community
San Francisco, CA

1992 - Present
Member, Board of Directors, Pan Med Ltd., Pacific Professional Building
San Francisco, CA

1996 - Present
Member, Board of Directors, Expedition Inspiration Fund for Brest Cancer Research
San Francisco, CA

1997 - Present
Chief, Division of Hematology and Oncology
California Pacific Medical Center
San Francisco, CA

Associations:

American Society of Clinical Oncology
American Society of Hematology
San Francisco Medical Association
California Medical Association
Brest Cancer Action

Research Activities:

Phase I trial of Immunotoxin (MoAb-RTA) in Colorectal Cancer.
Phase I trial of Immunotoxin (Moab - TRA) in Melanoma.

1992 - Present
Member, Gynecology Subcommittee Sothwest Oncology Group
San Antonio, TX

1995 - Present
Consultant, Bay Area SPORE for Brest Cancer Research

Medical Staff Activities:

1984 - 1992
Chairman, Cancer Committee, Pacific Medical Center
San Francisco, CA

1992 - Present
Member, Cancer Committee, California Pacific Medical Center
San Francisco, CA

1982 - 1984
Member, Medical Staff Executive Committee, Pacific Medical Center
San Francisco, CA

1995 - Present
Member, Medical Staff Executive Committee, Pacific Medical Center
San Francisco, CA

Awards and Special Activities:

1979
Golden Shovel Award for Best Teacher, Pacific Presbyterian Medical Center
San Francisco, CA

1995
Team Physician Expedition inspiration, Breast Cancer Survivors' Climb of 23,000 ft. Mt. Aconcagua, Argentina

1995
Honored by Assembly Resolution No. 623, California Legislature
Sacramento, CA

1996
Contributor, Time-Life Videos Educations Series, Colorectal Cancer

1996
Outstanding Researcher Award, California Pacific Medical Center
San Francisco, CA

Publications:

Grant K, Rodvien R, and Mielke CH, Jr.: "Altered Factor VIII in Acute Respiratory Failure." Abstract #54. American Society of Hematology 19th Annual Meeting, Boston, Mass., Dec. 4-7, 1976

Grant K, Rodvien R, and Mielke CH: "Altered Factor VIII Complexes in Patients with Respiratory Insufficiency." Thrombosis and Haemostasis, 40:326, 1978

Petz L, Gitlin J, Grant KM, Rodvien R, and Brotman M: Cimetidine-Induced Hemolytic Anemia: The Fallacy of Clinical Associations. J. Clin. Gastroent. 5:405-409, 1983

Ziegler JL, Bragg K, Abrams D, Beckstead J, Cogan M, Volberding P, Baer D, Wilkinson L, Rosenbaum E, Grant K, et al. "High Grade Non-Hodgkin's Lymphoma in Patients with AIDS." Ann. NY Acad Sci 437:412-419, 1985

Schoeppel S, Hoppe R, Abrams D, Baer D, Grant K, Horning S, Wilkinson L, Zeigler J: "Hodgkin's Disease in Homosexual Men - The San Francisco Bay Experience." Proceedings of American Society of Clinical Oncology #9, vol 5:3, 1986.

Bermudez MA, Grant KM, Rodvien R: Lymphoma in a Population With or At Risk for AIDS - Single Institution Experience. Blood (supp 1) 68(5):127 abstract #363, Nov., 1986

Bermudez M, Grant K, Rodvien R: Non-Hodgkin's Lymphoma in a Population With or At Risk for Acquired Immunodeficiency Syndrome: Indications for Intensive Chemotherapy. American Journal of Medicine 86:71-76, 1989.

Poplin E, Fleming T, MacDonald JS, Rodvien R, Grant K, Fisher R: "Amonafide Treatment of Refractory Esophageal Cancer." A Southwest Oncology Group Study, IND 11:47-51, 1993.

Training and professional Positions:

1994 - Present
Physician, Pacific Hematology-Oncology Associates, Califor Pacific Medical Center, San Francisco, CA.

1993-1994
Emergency Room Physician:
St. Luke's Hospital, New Bedford, MA.
Malden Hospital, Malden, MA.
New England Memorial Hospital, Stoneham, MA.

Locum Tenems Hematology-Oncology for the practices of Barbara Bjornson, M.D. and Roberto Mattii, M.D., Malden

1992-1993
Associate Physician, Divisions of experimental Medicine and Hematology/Oncology, Brigham and Women's Hospital, Bos MA.
Instructor in Medicine, Harvard Medical School, Boston, MA

1989-1991
Clinical and Research Fellow in Medicine, Hematology/Onco Massachusetts General Hospital, Boston, MA.

1988-1989
Emergency Room Physician, Malden Hospital, Malden, MA.

1985-1988
Internship and Residency in Internal Medicine, Boston City Hospital, Boston, MA.

Education:

1985
Albert Einstein College of Medicine, Bronx, N.Y. M.D.

1981
University of California, Berkeley, CA. A.B. in Biophysics with Honors.

Board Certifications:

Medical Oncology Hematology Intemal Medicine

Licensure and Certification:

Diplomate, American Board of Intemal Medicine
    Medical Oncology, 1993
    Hematology, 1992
    Intemal Medicine, 1988
Diplomate, National Board of Medical Examiners Califomia Medical License No. GO78339 Massachusetts Medical License No. 57661
AHA Certificate in Advanced Cardiac Life Support ACS Certificate in Advanced Trauma Life Support

Academic Appointments:

2002-Present
Assistant Clinical Professor of Medicine, University of Califomi. University of San Francisco School of Medicine.

1992-1993
Instructor in Medicine, Harvard Medical School

1989-1992
Research Fellow in Medicine, Harvard Medical School

Hospital Appointments:

1994- Present
Medical Staff Member
Califomia Pacific Medical Center, San Francisco, CA.

1993-1994
Medical Staff Member
Malden Hospital, Malden, MA.
New England Memorial Hospital, Stoneham, MA. Whidden Hospital, Everett, MA.

1992-1993
Associate Physician
Brigham and Women's Hospital

1989-1991
Clinical and Research Fellow in Medicine, Massachusetts General Hospital

Memberships:

Massachusetts Medical Society Suffolk County Medical Society American College of Physicians

Research Activities:

1990-1993
Hematology/Oncology Research Fellow with Thomas Stossel, M.D. and David Kwiatkowski, M.D. Ph., D. Massachusetts General Hospital and Brigham and Women's Hospital

Study of the effects of overexpression of the actin-binding protein gelsolin and deletion mutants of gelsolin on cellular motility and cellular transformation.

1984
Medical Student Research Associate with Karl Weisgraber, Ph. D. Gladstone Foundation Laboratories for Cardiovascular Research, University of California, San Francisco

Developed an assay using oligonucleotides to detect apolipoprotein E genetic polymorphisms

1981
Research Associate with Karl Weisgraber, Ph.D. Glastone Foundation Laboratories

Analyzed Apolipoprotein B structure

1980-1981
Senior Honors Thesis Research with Alex Nichols, Ph. D., Department of Biophysics, University of California, Berkeley

Studied the effects of dietary cholesterol on electrophoretic patterns of baboon lipoproteins

1979
American Heart Association, California Affiliate Student Research Associates with H.S. Sodhi, M.D., Ph. D. Departments of Biochemistry and Cardiology University of California, Davis

Studied effects of dietary cholesterol loading on human subjects

Bibliograhy:
Original Reports:

Tuan, B. Kwiatkowski, D.:Gelsolin, in Neuroscience Year: Supplement to the Encyclopedia of Neuroscience. Birkhauser Boston, 1993.

Lamb, 1., Allen P., Tuan, B., Janmey, P.: Modulation of Gelsolin Function: Activation at low ph overrides ca2+ requirement, J boil Chern 1993;268:8999.

Weisgraber, K.H. Newhouse, N.Y., Taylor, 1., Tuan, B. Newstruck, A.C., Davignon, J. Mahley, R.W.: Apolipoprotein E2 (ArgI58-Cys) Frequency in a hyperlipidemic FrenchCanadian Population of Apolipoprotein E2/2 Subjects; Determination by Synthetic Oligonucleotide Probes, Arteriosclerosis 1989; 9(1) : 50-57

Current Title:

Hematologist-Oncologist
Pacific Hematology-Oncology Associates, California Pacific Medical Center
San Francisco, CA,
September 1996 - Present.

Assistant Clinical Professor
Department of Medicine, University of California
San Francisco, CA
July 1997 - Present

Education:

Wesleyan University
Middletown, CT
B.A. in English, 1984

Tufts University School of Medicine
Boston, MA, M.D., May 1990

University of California, San Francisco, Department of Medicine
San Francisco, CA
Hematology-Oncology Fellowship, July 1994-September, 1996.

University of California, San Francisco, Department of Epidemiology and Biostatistics
San Francisco, CA
Outcomes Research and Clinical Epidemiology
August, 1996

Licenses and Certifications:

California Medical License: G072619

DEA: BB3139892

Diplomate, American Board of Internal Medicine, September, 1993

Diplomate in Medical Oncology, November, 1997

Principle positions held:

Staff Physician
Veterans Administration Medical Center
San Francisco, CA
July 1993 - July 1994

Staff Physician
San Francisco General Hospital Emergency Services
San Francisco, CA
July 1993 - July 1994

Clinical Instructor
Department of Medicine, University of California
San Francisco, CA
July 1993 - June 1997

Honors and awards:

Joseph Collins Foundation Grand, based on academic achievement and demonstrated interest in the arts and letters, 1988 - 1990

Alpha Omega Alpha, National Medical Honors Society, October 1989

Julius Krevans Award for clinical excellence, Department of Medicine, University of California, San Francisco, April 1991. Awarded to outstanding intern.

Excellence in Teaching Award, Department of Medicine, University of California, San Francisco, 1995. Awarded to outstanding teacher among clinical fellows by medicine house staff.

Professional Affiliation:

San Francisco Interns and Residents Association, 1990 - 1993.

UNWERSITY SERVICE

Interdepartmental Task Force to establish disability insurance coverage for housestaff. University of California, San Francisco Medical Center, 1991.

Fellowship education committee, established to review and redesign training program. Division of Hematology-Oncology, University of California, San Francisco, Fall 1995.

Interviewer, Internal Medicine Residing Program, California Pacific Medical Center, University of California, San Francisco, 1998 - Present.

Anticoagulation Quality Assurance: Developed guidelines and teaching tools to improv safety of anticoagulation. California Pacific Medical Center, San Francisco, 1997-1998.

Chairman, Science Committee, California Pacific Medical Center, San Francisco, CA. Develop and administer clinical research program in oncology for largest private hospital northern California. 2001-present

COMMUNITY SERVICE

Co-founder, Student, Student Committee on Racial Awareness, Wesleyan University, Middletown, CT. Developed and led workshops on racism on campus. 1981.- 1984.

Co-founder, AIDS Education Group, 'Tufts University School of Medicine, Boston, M Developed and led workshops on AIDS education for resident advisors, Tufts undergraduate campus. Fal1 986.

Co-founder Member, Kids in Chemotherapy Support. Helped start group of Big Brothers and Sisters to support children with cancer. New England Medical Center, Boston Floating Hospital for Children. 1987 - 1989.

RESEARCH EXPERIENCE

Research Intern, Division of Cell Biology, Children's Hospital, Boston, MA. Participated in the enzyme mapping of DNA from a family deficient in the fourth component of the human complement system. Summer 1983.

Research Technician, Division of Cell Biopsy, Children's Hospital, Boston, MA. Independently involved in the investigation of the structure and regulation of the acute phase response genes of the human immune system. 1984 - 1986.

Clinical Research Intern, Division of Adult Oncology, Hammersmith Hospital, London. Followed patients in Phase II clinical trial of radio labeled monoclonal antibodies against ovarian cancer- Summer 1986.

PUBLICATIONS

"Sweet's Syndrome During G-CSF Therapy." Parks, J. Mehrotra, B., Barnett, B., Baron A., Venook, A. Annals of Internal Medicine, 1992; 116:996-999

"Pseudomonas aeruginosa Bronchopulmonary Infection in Late HIV Disease." Baron, A. and Hollander, H. Presented at the 8th International AIDS Conference, Amsterdam, July 1992. American Review of Respiratory Diseases, 1993; 148:992-6

"Ketoconazole Retains Activity in Advanced Prostate Cancer Patients Who Have Progressed Despite Flutamide Withdrawal." Small, EJ., Baron, A.D., Pippin, L. Journal of Urology, 1997; 157:1204-07

"Simultaneous Anti-androgen Withdrawal and Treatment with Ketoconazole in Patients with Advanced Hormone Refractory Prostate Cancer." Small, E.S., Baron, A.D., Bok R. ASCO Abstract # 1117, 1997. Cancer 1997; 80: 1755-9

"Addition ofBevacizumab (rhuMab VEGF) to Bolus IFL in the First-Line Treatment of Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Trial." Hurwitz, Fehrenbacher, Novotny, Cartwright, Hainsworth, Heim, Berlin, Baron, Griffmg, Holmgren, Ferrara, Fyfe, Rogers, Ross, Kabbinnavar NEJM inpre.s.s

LECTURES

Prostate Cancer: Current Controversies and Advances, Medical Grand Rounds, California Pacific Medical Center, 4-97, Marin General, 12-97, Davies Medical Center, 198, Hawaiian Urologic Association, 1-98, John Muir Medical Center 7-98, San Francisco General Hospital 7-98, St. Mary's Medical Center 1-00, Phoenix Urological Association, 2002, Tuscon V AMC 2002.

Lung Cancer: Update on Current Treatment, Kaiser Permanente, 12-97, Marin General Hospital 12-98, Good Samaritan Hospital, San Jose,2003

Hypercoagulability and Its Treatment, Medical Grand Rounds, California Pacific Medical Center 12-98, Davies Medical Center 1-99.

Breast Cancer Prevention, Medical Grand Rounds, St. Joseph's Medical Center, Burbank, California 1-99.

Colorectal Cancer and Anti-Angiogenesis Therapies, Medical Grand Rounds, CPMC, 8/03

Kevin B. Knopf, M.D., M.P.H.

Medical Oncologist and Hematologist

Private practice in Hematology and Oncology. Pacific Hem/Onc Associates
San Francisco, CA

Prior Employment:

Private Practice/ Director of Clinical Research,
Annapolis Oncology/Hematology Center.
Annapolis, MD
Associate Staff, Oncology Section, Johns Hopkins (10%)

EDUCATION
Johns Hopkins School of Hygiene and Public Health Baltimore, MD

MPH degree granted, May 1997. Coursework in statistics and clinical trial design, health policy and management, outcomes assessment, management information systems.

University of California, San Francisco School of Medicine (UCSF) San Francisco, CA

M.D. degree granted, June 1992.

Massachusetts Institute of Technology Cambridge, MA

B.S. in Mechanical Engineering, June 1988.

CLINICAL TRAINING
National Cancer Institute/National Institutes of Health Bethesda, MD
Clinical Fellow, Medicine Branch, July 1997-2000
Research Fellow, Health Services and Economics Branch, July 1998-2000
Attending, Prostate and Ovarian Cancer Clinic 7/99 – 7/00

Evanston Hospital/Northwestern Medical School Evanston, IL

Internship and Residency in Internal Medicine, completed June 1996

Memorial Sloan Kettering Cancer Center New York, NY

Residency in Radiation Oncology, 1993-1994.
Awards/Honors/Research Grants
1987 Pi Tau Sigma (National Mechanical Engineering Honor Society)
1987 Undergraduate Research Opportunities Grant - MIT
1988 Dean’s Grant for Research on Fetal Heart Rate Variability - UCSF
1991 Bertram-Lobeer Memorial research Fellowship in Radiation Oncology
1998 Cancer Research Training Award - Division of Cancer Prevention and Control (2 years)

Invited Talks at Academic Centers/International Conferences

Northwestern Medical School
June 1999 “Quality of Life in Men with Prostate Cancer”,
June 1998 “Bowel Surveillance following Colon Cancer”

American Society of Clinical Oncology May 2001 “Quality of Life in Men with Prostate Cancer Treated with LHRH agonist vs. orchiectomy”

Grand Rounds VA West Virginia, May 2006 “Update on Colon and Rectal Cancer”

Grand Rounds Urology Dept. George Washington School of Medicine, 7/06 “Update on Prostate Cancer”

PROFESSIONAL ORGANIZATIONS
American Society for Clinical Oncology
American Society of Hematology
American College of Physicians
Reviewer –Journal of Supportive Oncology, Journal of Clinical Oncology, SEER special studies

HOSPITAL AND CANCER COMMITTEES
Anne Arundel Medical Center Annapolis, Maryland
Director of Clinical Research, DeCesaris Cancer Institute
Chairman, Institutional Review Board 2002-2006
Clinical Trial Advisory Committee 2001-
Cancer Committee 2000-
Quality Management Committee 2002 -
Colorectal Cancer Prevention Task Force, Member
Prostate Cancer Prevention Task Force, Member
Developer and Moderator; Colon/Rectal Cancer Support Group
Developer and Moderator, Genitourinary Tumor Board
Frequent speaker to community and physician groups
Leukemia and Lymphoma Society, Baltimore chapter
Patient Services Committee
California Pacific Medical Center
Chair, Cancer Quality Committee 2007-
Member, Cancer Committee

American Society of Clinical Oncology
Quality Oncology Project Initiative, Beta Member

PUBLICATIONS

Abstracts

Cheal EJ, Lott KC, Edwards WT, Knopf KB, and Hayes WC, Finite element modeling of failure processes in the skeleton, Orthopedic Biomechanics Laboratory, Department of Orthopedic Surgery, Charles A. Dana Research Institute, Harvard Medical School and MIT, Beth Israel Hospital, Boston, MA 02215, IEEEE Proceedings 1997

Knopf KB, Parer JT, Parer WJ, Gunn AJ, Williams CE, Gluckman PD (Intro by JM Roberts), A Comparison of visual assessment with mathematical indices of long and short term fetal heart rate variability, Dept Ob/Gyn and CVRI, Univ of Cal SF, Univ of Auckland NZ, Slideshow at American Federation for Clinical Research, Spring 1990, Carmel, California

Uhl V, Castro JR, Knopf K, and Phillips T, Heavy charged particle irradiation of bone sarcoma, International Journal of Radiation Oncology, Biology and Physics, Proceedings of the 33d Annual ASTRO Meeting 1991;21;Supp 1:1656-1657

Knop R, Shevrin D, Knopf K, et al. Pilot study of low dose weekly mitoxantrone in widely metastatic hormone refractory prostate cancer (HPRC), Proceedings of the American Society of Clinical Oncology 1993

Minsky B, Conti J, Huang Y, and Knopf K, Relationship of acute gastrointestinal (GI) toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. Proceedings of the American Society for Clinical Oncology 1995; 14:189

Knopf K, Brown M, and Kohn EC. Lack of improvement in survival in patients with relapsed or refractory epithelial ovarian cancer 1980-1997. Proceedings of the American Society of Clinical Oncology, 1998

Dahut W, Dyer V, P Arlen, Knopf K, et al. A randomized phase II trial of ketoconazole (KT) and alendronate (AL) versus high dose ketoconazole in androgen independent metastatic prostate cancer. American Urological Association Meeting, 2000 and Proceedings of the American Society of Clinical Oncology, 2001

Knopf KB, Warren JL, Feuer F and Brown M. Bowel Surveillance Patterns Following a Diagnosis of Colorectal Cancer in Medicare Beneficiaries. Proceedings of the American Society of Clinical Oncology, 2000 Poster Discussion

Knopf KB, Potosky AL, Clegg LX et al. Health Outcomes Following Primary Androgen Therapy in a Population-Based Cohort, Proceedings of the American Society of Clinical Oncology, 2001 Oral Presentation

Kiebert W, Knerer G, Liu H-T, Shih T, Brown R, Knopf K. Cost-Utility Analysis of a Randomized Clinical Trial comparing Docetaxel and Doxorubicin vs. Doxorubicin and Cyclophosphamide as first line chemotherapy for metastatic breast cancer. Proceedings of the American Society of Clinical Oncology, 2001

de Lissovoy G , Cassard SD, Knopf KB, Ciesla GN, Heyes A, and Silberman C. Duration and cost of treatment for stage IIIb-IV non-small cell lung cancer (NSCLC) patients receiving chemotherapy. Proceedings of the American Society of Clinical Oncology, 2002 231b.

Ellison GL, Brown ML, Warren JL and Knopf KB. Racial and ethnic differences in bowel surveillance procedures following colorectal cancer surgery with curative intent. Annals of Epidemiology 2002; 12(7):515

Mahedevia P, Baran RW, Knopf KB, Coop A. Cost Savings of Switching from IV to Oral 5-HT3 Antagonists for Prevention of Acute Chemotherapy Induced Nausea and Vomiting (CINV)
American Managed Care Pharmacy Annual Meeting 2004

Yabroff KR, Warren JL, Davis WW, Knopf K, Brown ML. Patient time costs for breast, colorectal, and lung cancer care. Presented at International Health Economics Association meeting 2005

Luo W, Nordstrom B, Ranganathan G, Linz H, Stokes M, Ross S, Knopf K. Adherence to guidelines for use of erythropoiesis stimulating proteins in patients with chemotherapy-induced anemia: Trends from electronic medical records. Submitted, American Society of Clinical Oncology 2007

Textbook Chapters

Knopf KB and Dahut W “Prostate Cancer”
Knopf KB and Kohn E “Ovarian Cancer”
Knopf KB “Hematopoietic Growth Factors”
Chapters in Bethesda Handbook of Oncology Lippincott Press, 2000
2nd Edition to be published 2002

PDQ Statement on Prevention of Oral Cancer, 4/99

Brawley O and Knopf KB, Chapter: Cancer in Special Populations, Haskell Textbook of Oncology 6th edition , 2000

Knopf KB, Brawley OW, and Pluda J. Chapter: AIDS and Women. Principles and Practice of Gynecologic-Oncology, Third Edition. Edited by W.J. Hoskins, C.A. Perez, and R.C. Young. Lippincott-Raven ,2000

Brown ML, Knopf KB, Marcus S and Lipscomb J. Economic Analysis and Clinical Research. Principles and Practices of Clinical Research, First Edition. Edited by Gallin J 2002

Papers

Knopf K, Parer JT, Espinoza MI, et al. Comparison of mathematical indices of fetal heart rate variability with visual assessment in the human and sheep. Journal of Developmental Physiology 1991;16:367-72

Uhl V, Castro JR, Knopf K, et al. Preliminary results in heavy charged particle irradiation of bone sarcoma. International Journal of Radiation Oncology, Biology and Physics 1992;24;4:755-759

Minsky BD, Conti JA, Huang Y, and Knopf K, Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. Journal of Clinical Oncology 1995;13;6:1409-1416

VonRoenn JH and Knopf K, Anorexia/Cachexia in patients with HIV: lessons for the Oncologist,. Oncology 1996;10;7:1049-1056

Knopf KB and Locker GY, Hodgkin’s disease and HIV infection [Letter], New England Journal of Medicine 1995;333;1:65-66

Brawley OW, Knopf K, and Merrill R. The epidemiology of prostate cancer part I: descriptive epidemiology. Seminars in Urologic Oncology 1998;14:187-192

Brawley OW, Knopf K, and Thompson I. The epidemiology of prostate cancer part II: the risk factors. Seminars in Urologic Oncology 1998;14:193-201

Brown ML and Knopf KB, Is colorectal cancer screening really cost-effective? Primary Care and Cancer 1999;19:15-21

Knopf KB. Book Review: Recent results in cancer research: Assessing the economic value of anticancer therapies. Journal of the National Cancer Institute 1999;91:1248-1249

Knopf KB, Warren JL, Feuer EJ, and Brown ML. Bowel Surveillance Patterns Following A Diagnosis of Colorectal Cancer in Medicare Beneficiaries, J Gastrointestinal Endoscopy, 2001:54:563-71

Dixon SC, Knopf KB and Figg WD. The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents. Pharmacological Reviews 53:73-91, 2001

Potosky AL, Knopf K, Clegg LX, et al. Quality-of-Life outcomes after primary androgen deprivation therapy: results from the prostate cancer outcomes study. J Clin Oncol 2001;19:3750-3757

Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS and Knopf KB. Utility of the SEER-Medicare Data to Identify Chemotherapy Use. Medical Care, Vol 40 (8) IV-55 to 61, 2002

Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R. Patterns of care for the treatment of bladder cancer
J Urology 2003;169:1697-1701

Ellison GL, Warren JL, Knopf KB and Brown ML. Racial Differences in the receipt of Bowel Surveillance Following Potentially Curative Colorectal Cancer Surgery Health Services Research 2003;38(6):1885-1904

Mariotto A, Warren J, Knopf K and Feuer E. The Prevalence of Colorectal Cancer Patients under Care in the United States Cancer 2003;98:1253-1251

Yabroff R, Warren J, Knopf K, Davis WW, Brown ML. Estimating Patient Time Costs Associated with Colorectal Cancer Care. Medical Care 2005;43(7): 640-648

L. Clark Paramore; Simu K. Thomas; Kevin B. Knopf; Lael S. Cragin; Kathy H. Fraeman
Estimating Costs of Care for Patients with Newly Diagnosed Metastatic Colorectal Cancer, Clinical Colorectal Cancer 6(1):52-58, 2006

Knopf K. Recent Developments in Head and Neck Cancer: The Role of Cetuximab.
Community Oncology 3(12) 4-5. December 2006

Knopf K. Another Step Forward in Renal Cell Carcinoma. Community Oncology 4(9):478-479, August 2007

Ongoing Blog on Breast Cancer
www.mybreastcancernetwork.com